Clinical Trials Logo

Clinical Trial Summary

assessment of NAFLD among diabetic, pre-diabetic and non diabetic participants Using Non Invasive Methods.And correlation between lab and radiological methods .

Clinical Trial Description

Non alcoholic fatty liver disease (NAFLD) is a major public health problem. with 10-30% prevalence worldwide , and is a common cause of chronic liver disease and the third most common cause of liver transplantation . NAFLD can range from simple steatosis in the absence of inflammation to nonalcoholic steatohepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC) . Major risk factors for NAFLD include obesity, hypertension , hyperlipidemia , hypertriglyceridemia , and type-2-diabetes mellitus (T2DM) . The gold standard in the diagnosis of NAFLD is liver biopsy; however, it is sometimes associated with some complications that include bleeding, bile leak, infection, and other potential life-threatening issues. The accuracy of the MRI, computed tomography, and ultrasound imaging in diagnosis of NAFLD is low; hence, Fibroscan was introduced . This is a non-invasive, simple-to-perform imaging modality with high accuracy to assess liver stiffness and hepatic fat deposition. Non-invasive diagnosis is based on clinical and biochemical markers, scoring models, and algorithms of methods which have sufficient sensitivity, specificity, and reproducibility . ;

Study Design

Related Conditions & MeSH terms

NCT number NCT04553796
Study type Observational
Source Assiut University
Contact Michael m Fekry, doctor
Phone +201207601294
Status Not yet recruiting
Start date January 1, 2021
Completion date March 1, 2022

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03625284 - Oral Dietary Fucoxanthin Rich Supplement for Liver Health N/A
Completed NCT02923804 - Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients N/A
Completed NCT03222206 - The Comparison of Effect Between Salsalate and Placebo in Osteoarthritis With Nonalcoholic Fatty Liver Disease Phase 4
Completed NCT04823676 - Efficacy and Safety of a Probiotic Composition as Adjunct in MAFL Management N/A
Completed NCT03186859 - Effects of Dietary Intervention and Surgery on NAFLD (Non-Alcoholic Fatty Liver Disease) N/A
Completed NCT02030977 - The Effects of Resveratrol Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis Phase 2/Phase 3
Recruiting NCT06176079 - Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease
Not yet recruiting NCT06138821 - ESG vs GLP-1RA vs ESG + GLP-1RA in Patients With Obesity, NAFLD and Advanced Fibrosis: A Randomized Controlled Trial Phase 4
Not yet recruiting NCT03801577 - Hepaxa Management of Non-alcoholic Fatty Liver Disease N/A
Completed NCT05804422 - Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults NAFLD Patients (DELI_NAFLD Study) N/A
Recruiting NCT04625166 - Combi-elastography Assessment of Chronic Liver Disease Multi-center Study
Recruiting NCT05523024 - Effect of Probiotics or Berberine in Hepatic Steatosis Markers, Cardiometabolic and Microbiotic Profile in NAFL. N/A
Not yet recruiting NCT05822622 - Relationship Between Heart Failure With Preserved Ejection Fraction and Nonalcoholic Fatty Liver Disease.